Or are they buying at 2.80, with the intention to support the Regent bid and sell to Regent at 3.30. A quick 18%.
Or are they buying at 2.80 knowing that the whole saga is drawing to a close, and the shareprice will soar once the independent report shows the revenue prospects of this company and the bid is rejected.
All will be revealed shortly.
- Forums
- ASX - By Stock
- BCI
- increased cons min shareholding
increased cons min shareholding, page-3
Featured News
Add BCI (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.8¢ |
Change
0.003(0.82%) |
Mkt cap ! $887.3M |
Open | High | Low | Value | Volume |
30.5¢ | 30.8¢ | 30.5¢ | $5.311K | 17.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 121321 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 28715 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 121321 | 0.305 |
27 | 308298 | 0.300 |
6 | 141948 | 0.295 |
8 | 160606 | 0.290 |
2 | 26564 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 28715 | 10 |
0.315 | 94801 | 4 |
0.320 | 197203 | 4 |
0.325 | 251948 | 2 |
0.330 | 123614 | 7 |
Last trade - 12.12pm 12/11/2024 (20 minute delay) ? |
Featured News
BCI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online